Translational molecular imaging in exocrine pancreatic cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30225616.
- Also identified by DOI 10.1007/s00259-018-4146-5 and PMC identifier 6208802.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancers. Late diagnosis and failure of chemotherapy and radiotherapy are all too common, and many patients die soon after diagnosis. Here, we make the case for the increased use of molecular imaging in PDAC preclinical research and in patient management.
Medical subject headings
- Molecular Imaging
- Pancreas, Exocrine
- Pancreatic Neoplasms